Ernährung und Wohlbefinden — Bedeutung von Nahrungsmittelunverträglichkeiten

  • Dieter Genser

Auszug

Sowohl das körperliche als auch das psychische Wohlbefinden können durch Nahrungsmittelunverträglichkeiten empfindlich gestört werden. In diesem Beitrag sollen exemplarisch spezifische Nahrungsmittelunverträglichkeiten wie Laktoseintoleranz und Fruktosemalabsorption, sowie unspezifische Nahrungsmittelunverträglichkeiten wie Reizdarmsyndrom und Morbus Crohn besprochen werden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Addolorato G, Capristo F, Stefanini GF, Gasbarrini G (1997) Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol 32: 1013–1021PubMedGoogle Scholar
  2. Ballegaard M, Bjergström A, Bröndum S, Hylander E, Jensen L, Ladefoged K (1997) Self-reported food intolerance in chronic inflammatory bowel disease. Scand J Gastroenterol 32: 569–571PubMedCrossRefGoogle Scholar
  3. Barclay GR, McKenzie H, Pennington J, Parratt D, Pennington CR (1992) The effect of dietary yeast on the activity of stable chronic Crohn’s disease. Scand J Gastroenterol 27: 196–200PubMedGoogle Scholar
  4. Benton D (2002) Carbohydrate ingestion, blood glucose and mood. Neurosci Biobehav Rev 26: 293–308PubMedCrossRefGoogle Scholar
  5. Beyer PL, Caviar EM, McCallum RW (2005) Fructose intake at current levels in the United States may cause gastrointestinal distress in normal adults. J Am DietAssoc 105: 1559–1566Google Scholar
  6. Dapoigny M, Stockbrügger RW, Azpiroz F, Collins S, Coremans G, Müller-Lissner S, Oberndorff A, Pace F, Smout A, Vatn M, Whorwell P (2003) Role of alimentation in irritable bowel syndrome. Digestion 67: 225–233PubMedCrossRefGoogle Scholar
  7. De Vrese M, Stegelmann A, Richter B, Fenselau S, Laue C, Schrezenmeir J (2001) Probiotics — compensation for lactase insufficiency. Am J Clin Nutr 73[Suppl]:421S–429SPubMedGoogle Scholar
  8. Di Stefano M, Veneto G, Malservisi S, Cechetti L, Minguzi L, Strocchi A, Corazza GR (2002) Lactose Malabsorption and intolerance and peak bone mass. Gastroenterology 122: 1793–1799PubMedCrossRefGoogle Scholar
  9. Enattah NS, Sahi T, Savilahti E, Terwilliger JD, Peltonen L, Järvelä I (2002) Identification of a variant associated with adult-type hypolactasia. Nature Genet 30(2): 233–237PubMedCrossRefGoogle Scholar
  10. Francis CY, Whorwell PJ (1994) Bran and irritable bowel syndrome: time for reappraisal Lancet 344: 39–40PubMedCrossRefGoogle Scholar
  11. Genser D (1996) Ernährungsgewohnheiten, Nah-rungsmittelintoleranzen und Nahrungsmittelantikörper bei Patienten mit Morbus Crohn. Diplomarbeit an der naturwissenschaftlichen Fakultät der Universität WienGoogle Scholar
  12. Hertzler SR, Savaiano DA (1996) Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance. Am J Clin Nutr 64: 232–236PubMedGoogle Scholar
  13. Horwitz BJ, Fisher RS (2001) The irritable bowel syndrome. N Engl J Med 344: 1846–1850PubMedCrossRefGoogle Scholar
  14. Jones VA, Workman E, Freeman AH, Dickinson RJ, Wilson AJ, Hunter JO (1985) Crohn’s disease: Maintenance of remission by diet. Lancet II: 177–180CrossRefGoogle Scholar
  15. Karamanolis G, Tack J (2006) Nutrition and motility disorders. Best Pract Res Clin Gastroenterol 20(3): 485–505PubMedCrossRefGoogle Scholar
  16. Kasper H (2004) Erkrankungen der Gastrointestinalorgane. In: Kasper H (Hrsg) Ernährungsmedizin und Diätetik. Elsevier, Urban & Fischer, München, S 127–244Google Scholar
  17. Kinaciyan T (2005) Nahrungsmittelunverträglichkeiten. In: Widhalm K (Hrsg) Ernährungsmedizin. ÖÄK, Wien, S 393–413Google Scholar
  18. King TS, Elia M, Hunter JO (1998) Abnormal colonic fermentation in irritable bowel syndrome. Lancet 352: 1187–1189PubMedCrossRefGoogle Scholar
  19. Koletzko S, Koletzko B (2006) Wenn Zucker krank machen — Maldigestion und metabolische Unverträglichkeiten. Aktuel Ernaehr Med 31[Suppl 1]: S68–75CrossRefGoogle Scholar
  20. Kluthe R, Dittrich A, Everding R, Gebhardt A, Hund-Wissner E, Kasper H, Rottka H, Rabast U, Weingard W, Wild M, Wirth A, Wolfram G (2004) Das Rationalisierungsschmema 2004 des Bun des verbandes deutscher Ernährungsmediziner (BDEM) e.V. Aktuel Ernaehr Med 29: 245–253CrossRefGoogle Scholar
  21. Ladas SD, Grammenos I, Tassios PS, Raptis SA (2000) Coincidental malabsorption of lactose, fructose, and sorbitol ingested at low doses is not common in normal adults. Dig Dis Sci 45(12): 2357–2362PubMedCrossRefGoogle Scholar
  22. Ledochowski M, Widner B, Fuchs D (2000) Fruk-tosemalabsorption. J Ernährungsmed 2(3): 10–14Google Scholar
  23. Ledochowski M, Widner B, Bair H, Probst T, Fuchs D (2000) Fructose-and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scand J Gastroenterol 35: 1048–1052PubMedCrossRefGoogle Scholar
  24. Locke GR III, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ (2000) Risk factors of irritable bowel syndrome: Role of analgesics and food sensitivities. Am J Gastroenterol 95: 157–165PubMedCrossRefGoogle Scholar
  25. Mearin F, Badía X, Balboa A, Baró E, Caldwell E, Cucala M, Díaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ (2001) Irritable bowel syndrome varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 36: 1155–1161PubMedCrossRefGoogle Scholar
  26. Main J, McKenzie H, Yeaman GR, Kerr MA, Robson D, Pennington CR, Parrat D (1988) Antibody to Saccharomyces cerevisiae (bakers’ yeast) in Crohn’s disease. BMJ 297: 1105–1106PubMedCrossRefGoogle Scholar
  27. Monsbakken KW, Vandvik PO, Farup PG (2006) Perceived food intolerance in subjects with irritable bowel syndrome — etiology, prevalence and consequences. Eur J Clin Nutr 60: 667–672PubMedCrossRefGoogle Scholar
  28. Montalto M, Curigliano V, Santoro L, Vastola M, Cammarota G, Manna R, Gasbarrini A, Gasbarrini G (2006) Management and treatment of lactose malabsorption. World J Gastroenterol 12(2): 187–191PubMedGoogle Scholar
  29. Niec AM, Frankum B, Talley NJ (1998) Are adverse food reactions linked to irritable bowel syndrome? Am J Gastroenterol 95: 2184–2190CrossRefGoogle Scholar
  30. Obermayer-Pietsch (2006) Genetics of Osteoporosis. Wien Med Wochenschr 156(5–6): 162–167PubMedCrossRefGoogle Scholar
  31. Ortolani C, Pastorello EA (2006) Food allergies and food intolerances. Best Pract Res Clin Gastroenterol 20(3): 467–483PubMedCrossRefGoogle Scholar
  32. O’Sullivan M, O’Morain C (2006) Nutrition in inflammatory bowel disease. Best Pract Res Clin Gastroenterol 20(3): 561–573PubMedCrossRefGoogle Scholar
  33. Parker SL, Krondl M, Coleman P (1993) Foods perceived by adults as causing adverse reactions. J Am Diet Assoc 93: 40–44PubMedCrossRefGoogle Scholar
  34. Peveler R, Mayou R, Young E, Stoneham M (1997) Psychiatric aspects of food-related physical symptoms: A community study. J Psychosom Res 41(2): 149–159CrossRefGoogle Scholar
  35. Pearson M, Teahon K, Levi AJ, Bjarnason I (1993) Food intolerance and Crohn’s disease. Gut 34: 783–787PubMedCrossRefGoogle Scholar
  36. Pimentel M, Chow EJ, Lin HC (2000) Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 95: 3503–3506PubMedCrossRefGoogle Scholar
  37. Plein K, Hotz J (1993) Therapeutic effects of saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn’s disease with special respect to chronic diarrhea — a pilot study. Z Gastroenterol 31:129–134PubMedGoogle Scholar
  38. Rabast U, Horn M (2003) Häufigkeit der unspezifischen Lebensmittelintoleranz bei Patienten mit chronisch entzündlichen Darmerkrankungen. Aktuel Ernaehr Med 38: 106–112CrossRefGoogle Scholar
  39. Rasinperä H, Forsblom C, Enattah NS, Halonen P, Salo K, et al (2005) The C/C-1390 genotype of adult-type hypolactasia is associated with an increased risk of colorectal cancer in the Finish population. Gut 54: 643–647PubMedCrossRefGoogle Scholar
  40. Riordan AM, Hunter JO, Cowan RE, Crampton JR, Davidson AR, Dickinson RJ, Dronfield MW, Fellows IW, Hishon S, Kerrigan GNW, Kennedy HJ, McGouran RCM, Neale G, Saunders JHB (1993) Treatment of active Crohn’s disease by exclusion diet: East Anglian Multicentre Controlled Trial. Lancet 342: 1131–1134PubMedCrossRefGoogle Scholar
  41. Savaiano DA, Boushey CJ, McGabe GP (2006) Lactose intolerance symptoms assessed by meta-analysis: A grain of truth that leads to exaggeration. J Nutr 136: 1107–1113PubMedGoogle Scholar
  42. Souci SW, Fachmann W, Kraut H (2000) Die Zusammensetzung der Lebensmittel, Nährwerttabellen. medpharm/CRC PressGoogle Scholar
  43. Stange EF, Schmid U, Fleig EW, Ditschuneit H (1990) Ausschlußdiät bei Morbus Crohn: Eine kontrollierte, randomisierte Studie. Z Gastroenterol 28: 561–564PubMedGoogle Scholar
  44. Stein J (2003) Leitlinien der DGVS: Ernährung. Z Gastroenterol 41: 62–68PubMedCrossRefGoogle Scholar
  45. Suarez FL, Savaiano DA, Levitt MD (1995) A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance. N Engl J Med 333: 1–4PubMedCrossRefGoogle Scholar
  46. Vermeire S, Joossens S, Peeters M, Monsuur F, Marien G, Bossuyt X, Groenen P, Vlietinck R, Rutgeerts P (2001) Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology 120: 827–833PubMedCrossRefGoogle Scholar
  47. Wood JD (2001) Enteric nervous system, serotonin, and the irritable bowel syndrome. Curr Opin Gastroenterol 17: 91–97PubMedCrossRefGoogle Scholar
  48. Young E, Stoneham MD, Petruckevitch A, Barton J, Rona R (1994) A population study of food intolerance. Lancet 343: 1127–1130PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2007

Authors and Affiliations

  • Dieter Genser
    • 1
  1. 1.Österreichisches Bundesinstitut für GesundheitswesenGesundheit Österreich GmbHWien

Personalised recommendations